Iranian Journal of Pharmaceutical Research

1. Benefits and Risks of Melatonin in Hepatic and Pancreatic Disorders; A Review of Clinical Evidences

Volume 20, Issue 3, Summer 2021, Pages 102-109

Saeed Abdi; Mohammad Abbasinazari; Sara Ataei; Neda Khanzadeh-Mogaddam; Negin Keshvari

2. Efficacy and Safety of Melatonin as an Adjunctive Therapy on Clinical, Biochemical, and Quality Of Life in Patients with Ulcerative Colitis

Volume 20, Issue 2, Spring 2021, Pages 197-205

Shabnam Shahrokh; Roja Qobadighadikolaei; Mohammad Abbasinazari; Mehrdad Haghazali; Hamid Asadzadeh Aghdaei; Saeed Abdi; Hedieh Balaii; Neda Khanzadeh-Moghaddam; Mohammad Reza Zali

3. Effect of Bedtime Melatonin Administration in Patients With Type 2 Diabetes: A Triple-Blind, Placebo-Controlled, Randomized Trial

Volume 18, Special Issue, Autumn 2019, Pages 258-268

Amir Farrokhian; Maryam Tohidi; Noushin Sadat Ahanchi; Davood Khalili; Mahtab Niroomand; Arash Mahboubi; Arash Derakhshi; Mohammad Abbasinazari; Farzad Hadaegh

4. Does Twice-weekly Cabergoline Improve Anthropometrical and Biochemical Profiles in Prediabetes? A Randomized Double-blind Clinical Trial Pilot Study

Volume 14, supplement, Winter 2015, Pages 77-86

Navid Saadat; Hadi Esmaily; Mohammad Abbasinazari; Maryam Tohidi; Jamshid Salamzadeh; Farzad Hadaegh; Maryam Tolabi; Maryam Kalantar-Hormozi; Maryam Dibaj

1. Benefits and Risks of Melatonin in Hepatic and Pancreatic Disorders; A Review of Clinical Evidences

2. Efficacy and Safety of Melatonin as an Adjunctive Therapy on Clinical, Biochemical, and Quality Of Life in Patients with Ulcerative Colitis

3. Effect of Bedtime Melatonin Administration in Patients With Type 2 Diabetes: A Triple-Blind, Placebo-Controlled, Randomized Trial

4. Does Twice-weekly Cabergoline Improve Anthropometrical and Biochemical Profiles in Prediabetes? A Randomized Double-blind Clinical Trial Pilot Study

Journal Archive